Nidonil

Nidonil Tab 80mg – A Comprehensive Oral Hypoglycemic Solution.

Nidonil Tab 80mg is an oral hypoglycemic medication designed to help manage blood sugar levels in individuals with type 2 diabetes. Manufactured by Martin Dow Pharmaceuticals (Pak) Ltd, this tablet contains the active ingredient Gliclazide, which works by stimulating the secretion of insulin from the pancreas, thereby reducing blood glucose levels.

Key Features:

• Active Ingredient: Gliclazide.
• Dosage: 80mg per tablet.
• Pack Size: 2×10 tablets.
• Indication: Non-insulin-dependent diabetes (type 2) in adults.
• Dosage Instructions: The recommended initial dose is 1 tablet per day, with adjustments made based on individual glycaemic response. The standard dosage is 2 tablets per day, taken as two daily doses. For patients over 65, the initial dose is ½ tablet per day, with gradual increases as needed.

Important Information:

• Hypoglycemia Risk: Patients should be aware of the symptoms of hypoglycemia and take necessary precautions, especially when driving or operating machinery.
• Interactions: Certain medications, such as miconazole and phenylbutazone, can increase the risk of hypoglycemia when taken with Gliclazide.

Usage Guidelines:

• Dietary Measures: Patients should follow dietary advice and engage in regular exercise to help manage blood glucose levels.
• Blood Sugar Monitoring: Regular monitoring of blood glucose levels is crucial to ensure effective control of diabetes.

Nidonil Tab 80mg is a reliable and effective solution for managing type 2 diabetes, helping patients achieve better glucose control and improve their overall health.